Provided by Tiger Trade Technology Pte. Ltd.

Stifel

75.79
+0.28000.37%
Post-market: 75.790.0025+0.00%19:30 EDT
Volume:2.79M
Turnover:211.09M
Market Cap:11.44B
PE:13.55
High:76.02
Open:75.26
Low:74.29
Close:75.51
52wk High:89.83
52wk Low:67.81
Shares:151.00M
Float Shares:141.93M
Volume Ratio:3.04
T/O Rate:1.97%
Dividend:1.33
Dividend Rate:1.75%
EPS(TTM):5.59
EPS(LYR):3.91
ROE:16.43%
ROA:2.25%
PB:2.15
PE(LYR):19.37

Loading ...

Cipher Pharmaceuticals price target lowered to C$20 from C$22 at Stifel

TIPRANKS
·
Aug 17

Sylogist price target lowered to C$3.25 from C$3.75 at Stifel

TIPRANKS
·
Aug 17

DBS Reaffirms Their Buy Rating on SF Real Estate Investment Trust (8ET)

TIPRANKS
·
Aug 17

Yeti price target raised to $45 from $42 at Stifel

TIPRANKS
·
Aug 16

Bird Construction price target raised to C$87 from C$85 at Stifel

TIPRANKS
·
Aug 16

Canadian Tire price target raised to C$220 from C$215 at Stifel

TIPRANKS
·
Aug 16

Mattr Corp. price target raised to C$26 from C$23 at Stifel

TIPRANKS
·
Aug 16

Week's Best: Rich People Mess up with Money, Too

Dow Jones
·
Aug 15

Stifel Nicolaus Reaffirms Their Hold Rating on HLS Therapeutics Inc (HLS)

TIPRANKS
·
Aug 15

Heartflow is Maintained at Buy by Stifel

Dow Jones
·
Aug 14

Celcuity Price Target Cut to $150.00/Share from $175.00 by Stifel

Dow Jones
·
Aug 14

Stifel Nicolaus Reaffirms Their Buy Rating on Wolverine World Wide (WWW)

TIPRANKS
·
Aug 14

Stifel Nicolaus Sticks to Their Hold Rating for Yeti Holdings (YETI)

TIPRANKS
·
Aug 14

Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)

TIPRANKS
·
Aug 14

MacroGenics (MGNX) Gets a Hold from Stifel Nicolaus

TIPRANKS
·
Aug 14

Stifel Upgrades Intuitive Machines to Buy From Hold, Adjusts PT to $26 From $32

MT Newswires Live
·
Aug 14

SF Real Estate Investment Trust (SEHK:2191) Stock Recovers Profit As Revenue Softens

Simply Wall St.
·
Aug 14

Stifel Nicolaus Reaffirms Their Hold Rating on Sylogist (SYZ)

TIPRANKS
·
Aug 14

Stifel Nicolaus Remains a Buy on Zedcor Energy Inc (ZDC)

TIPRANKS
·
Aug 13

Stifel Nicolaus Sticks to Its Buy Rating for Cipher Pharmaceuticals (CPHRF)

TIPRANKS
·
Aug 13